Search

everythinglearnresearchcommunity

for

Search:↓

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Korean women with female pattern hair loss have higher levels of ferritin, testosterone, and vitamin D than average.

A rare case of isolated trichothiodystrophy was identified, marked by brittle hair with low sulfur content.

The fuzzy gene is crucial for controlling hair growth cycles.

A rare case of trichothiodystrophy was found with autism, seizures, and mental retardation.

A specific DNA region is crucial for Foxn1 gene expression in thymus cells but not in hair follicles.

Tofacitinib might be used to treat hair loss.

Removing HIF-P4H-2 from certain skin cells in mice causes hair loss on the body but not the head.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Oxidative stress may worsen female pattern hair loss and could help track the disease and treatment.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

A new treatment using gold nanoclusters can safely reduce unwanted hair growth.

The R343H mutation in the VDR gene causes vitamin D-resistant rickets with alopecia by impairing specific gene activity.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Acitretin effectively improved the woman's skin condition.

Replenishing iron after phlebotomy can cause relapse in porphyria cutanea tarda.

Certain gene variations and low adiponectin levels may increase the risk of hair loss in Egyptians.

Tofacitinib is an effective and safe treatment for alopecia areata.

LHX2 is essential for hair follicle development, controlled by NF-κB and TGFβ2 signaling.

Maternal melatonin improves offspring hair growth by affecting specific proteins and pathways.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

The woman had a genetic condition causing high cortisol and androgen levels, treatable with dexamethasone.

Enhancing Factor is found in growing tissues like young mouse intestines and skin but not in adults.

Fetuin-A levels are higher in PCOS patients, suggesting it may play a role in the condition.

Low iron levels and obesity are linked to chronic hair loss in women.

Two genetic disorders affect biotin metabolism, causing severe skin, hair, and metabolic issues.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.